Statistics

Total Visits

Views
BIM and SHP2 expression levels to predict clinical outcome to EGFR tyrosine kinase inhibitors (TKI) in EGFR-mutant non-small-cell lung cancer (NSCLC) patients (p)83

Select a period of time:

Number of views in the range

Views
BIM and SHP2 expression levels to predict clinical outcome to EGFR tyrosine kinase inhibitors (TKI) in EGFR-mutant non-small-cell lung cancer (NSCLC) patients (p)39

Views

Views
May 20250
June 20252
July 202524
August 20250
September 20251
October 20251
November 202511
Download CSV file
 untranslated
 untranslated

Top country views

Views
Brazil18
United States9
Argentina4
United Kingdom2
Ecuador1
Kenya1
Peru1
Trinidad and Tobago1
Uruguay1
Venezuela1
 

Top cities views

Views
Rio de Janeiro2
Altamonte Springs1
Barry1
Belford Roxo1
Belo Horizonte1
Belém1
Botucatu1
Buenos Aires1
Cacoal1
Chaguanas1